Pluri Congratulates Mesoblast on FDA Approval of First Mesenchymal Stromal Cell Therapy for Steroid-Refractory Acute Graft-Versus-Host Disease
Silviu and the team at Mesoblast have opened a new chapter in harnessing MSC therapies to treat devastating conditions like SR-aGVHD. This approval validates the immense therapeutic promise of MSCs and inspires all of us working in this space to redouble our efforts to bring innovative solutions to patients in need.
A collaborative effort by experts from, Genentech, and the Chan-Zuckerberg Initiative aims to leverage artificial ...
The bill thrusts New Jersey into a growing national movement by some schools to implement cell phone bans or restrictions to ...
Digital Forensics experts can determine where you have been in the past by examining your Cell Site Location Information ...
Caltech researchers have developed a new method to map the positions of hundreds of DNA-associated proteins within cell ...
Android: Hold down the power button, or the power button and the volume down key (depending on your Android phone), until the ...
Alex Murdaugh sits in the Colleton County Courthouse in Walterboro, South Carolina. TNS. In the ongoing legal battle ...
In 2022 alone, over 20 million people were diagnosed with cancer, and nearly 10 million died from the disease, according to ...
Natassa Adamou was diagnosed with a rare type of blood cancer earlier this year and her condition has since progressed.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback